Spain · Delayed Price · Currency is EUR BME:YMRE Statistics
Total Valuation
BME:YMRE has a market cap or net worth of EUR 95.00 million. The enterprise value is 138.58 million.
| Market Cap | 95.00M |
| Enterprise Value | 138.58M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BME:YMRE has 122.58 million shares outstanding.
| Current Share Class | 122.58M |
| Shares Outstanding | 122.58M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.14 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.93 |
| EV / Sales | 3.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.65.
| Current Ratio | 4.69 |
| Quick Ratio | 4.69 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.39 |
Financial Efficiency
Return on equity (ROE) is -22.03% and return on invested capital (ROIC) is -2.48%.
| Return on Equity (ROE) | -22.03% |
| Return on Assets (ROA) | -1.07% |
| Return on Invested Capital (ROIC) | -2.48% |
| Return on Capital Employed (ROCE) | -2.41% |
| Weighted Average Cost of Capital (WACC) | 5.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 2 |
| Asset Turnover | 0.23 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -640,942 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.28% in the last 52 weeks. The beta is 0.28, so BME:YMRE's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -8.28% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 0.80 |
| Relative Strength Index (RSI) | 0.00 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YMRE had revenue of EUR 44.42 million and -20.00 million in losses.
| Revenue | 44.42M |
| Gross Profit | 3.87M |
| Operating Income | -3.33M |
| Pretax Income | -19.93M |
| Net Income | -20.00M |
| EBITDA | n/a |
| EBIT | -3.33M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 10.21 million in cash and 51.03 million in debt, with a net cash position of -40.82 million or -0.33 per share.
| Cash & Cash Equivalents | 10.21M |
| Total Debt | 51.03M |
| Net Cash | -40.82M |
| Net Cash Per Share | -0.33 |
| Equity (Book Value) | 78.12M |
| Book Value Per Share | n/a |
| Working Capital | 12.48M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 8.71%, with operating and profit margins of -7.50% and -45.03%.
| Gross Margin | 8.71% |
| Operating Margin | -7.50% |
| Pretax Margin | -44.87% |
| Profit Margin | -45.03% |
| EBITDA Margin | n/a |
| EBIT Margin | -7.50% |
| FCF Margin | n/a |
Dividends & Yields
BME:YMRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -21.05% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |